Supplementary Figures 1-12 from Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors

Abstract

<p>PDF file - 1.3MB, Supplementary data on MAPK1 copy number and expression, combination treatment with WZ4002 and PI3K inhibitors, impact of MEK1 K57N on WZ4002 sensitivity, Mapk1 copy number analyses and NF1 and dusp expression in drug sensitive and resistant mouse tumors</p>